Natco Pharma Limited has informed the Exchange regarding Appointment of Mr Yarramshetty Krishna Rao as Senior Vice President Operations of the company w.e.f. Jun 16, 2025.
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natco Pharma has appointed Mr Yarramshetty Krishna Rao as Senior Vice President - Operations at its Mekaguda facility, effective June 16, 2025. He brings 33 years of experience in Indian bulk drug/API manufacturing, including 20 years as a Unit Head. He was most recently Senior Director/Site Head of the API manufacturing unit at Dr. Reddy's Laboratories in Hyderabad. The disclosure has been made under SEBI's Listing Regulations, and his appointment terms are as per the company's policy. This is a senior management-level change, not a board or CEO appointment.
Hiring an experienced operations leader from a major pharma peer like Dr. Reddy's is a positive operational signal, suggesting Natco is strengthening its manufacturing leadership at the Mekaguda unit. For shareholders, this is a routine senior management update with no immediate impact on stock price or board composition.